You are here:--PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?

PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?

REVIVE Webinar Series:

PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?

Speaker: William Hope, Centre of Antimicrobial Pharmacodynamics, University of Liverpool

Moderator: Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria

* This presentation was also part of the GARDP and CARB-X co-organized session ‘Expediting antibacterial development: core lessons and key tools for a rocky road’ at the 28th ECCMID in Madrid in April 2018. *

In this webinar, William Hope talked about the role of pharmacokinetics and pharmacodynamics for antimicrobial drug development. He discussed the EMA guideline on the use of PK/PD and basic studies to inform dose finding strategies and also advised on realistic benchmarking, endpoints, and interpretation of study results.


We hosted a live webinar with William Hope and Ursula Theuretzbacher on June 26, 2018, 17:00-18:30 CEST.

You can watch the recording below.

If you have questions or comments, please let us know. Do so by posting them in our forum or submitting them via the ‘Talk to an expert’ feature. You can also send questions to: info.revive@dndi.org.

2018-07-31T06:49:01+00:00